Leviticus Cardio Awarded R&D Grant from BIRD Foundation

Editor’s note: News of this announcement appeared in No Camels and The Times of Israel.

Leviticus Cardio, inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) system, together with Jarvik Heart, a global leader in left ventricular assist devices (LVAD), have been awarded a $950,000 grant from the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.

The grant will help fund the ongoing development of a fully implanted wireless VAD system which utilizes Jarvik Heart’s pump together with Leviticus’ CET technology. It will help thousands of patients with severe heart failure live longer and with a better quality of life.

BIRD’s funding will be integrated into the first, $2.9 million, phase of the project, designed to reach clinical regulatory trials for the hybrid system.

This comes on the heels of a highly successful long-term multi-animal trial that extended over 6 months.